Accomplished Industry Executive to Lead Commercial Strategy and Launch Readiness   Watertown, Mass., September 8, 2026 – Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease, today announced the appointment of Nicole Sweeny as Chief Commercial Officer.   “As we continue […]